Cargando…
Loading, please waitCargando…
Loading, please waitEvaluation & Candidacy
Before any regenerative protocol begins at Regeneris Therapy in Cancún, México, a licensed physician reviews your full medical picture — history, imaging, labs, current medications, and goals — to determine whether you are a candidate, which modality fits, and what your individualized plan should look like. This page explains exactly what that evaluation covers, why each step matters, and how candidacy is decided under COFEPRIS-regulated standards.
At Regeneris Therapy in Cancún, México, the stem cell evaluation is a free, physician-led review of your clinical history, imaging, labs, and personal goals — designed to decide honestly whether you are a candidate, which modality fits best, and what an individualized protocol would look like. Candidacy depends on a real diagnosis, realistic goals, and the absence of clear contraindications (such as active malignancy or uncontrolled infection), not on a marketing label. Only after this evaluation does our medical team issue a personalized written quote — there are no published prices online.
Definition
A regenerative-medicine evaluation is a structured clinical assessment with one purpose: to decide whether stem cell therapy is appropriate for you — and, if so, which protocol, which cell source, and what realistic outcome to expect. It is not a sales meeting and not a checklist. It is the same kind of careful diagnostic conversation that precedes any serious medical intervention, adapted to the specifics of regenerative care. In Cancún, México this evaluation is performed by a licensed Mexican physician, documented in your file, and used as the basis for every later decision.
The evaluation is, in short, the moment the clinic earns the right to make a recommendation. Everything that follows — cell source, route of administration, number of sessions, follow-up — flows from this single conversation.
Step by step
Each Regeneris evaluation in Cancún, México follows the same five-step structure. The exact time per step varies with the complexity of your case, but the sequence is consistent — because each step exists to answer a specific clinical question before the next one begins.
We collect a structured medical history: chronic conditions, prior surgeries, allergies, current medications and supplements, imaging studies (MRI, CT, ultrasound, radiographs), recent lab work, and the specific goals motivating your visit. Most patients send these by encrypted upload before their consultation so the physician arrives prepared and the conversation is substantive from the first minute.
A licensed Mexican physician reads your file end-to-end and correlates it with the index condition you want to treat. The question is not 'can we offer stem cells?' but 'does the picture support regenerative therapy for this specific problem, in this specific patient, right now?' Gaps in imaging or labs are flagged and ordered locally in Cancún if needed.
For orthopedic and structural cases, the physician performs a focused physical examination on your visit: range of motion, joint stability, gait, neurovascular checks, and palpation of the target area. For systemic indications (autoimmune-adjacent, post-viral, longevity), the exam emphasizes vitals, general state, and any red flags that warrant deferral.
The physician issues an explicit candidacy decision: you are a candidate, you are not a candidate, or you are a candidate once a specific condition is addressed (for example, stabilizing blood pressure, finishing oncology follow-up, or completing imaging). This decision is documented and explained to you directly — never as a hidden line in a quote.
Only after a positive candidacy decision do we issue a personalized written plan: cell source (autologous or allogeneic), route of administration (intravenous, intra-articular, intradiscal), number of sessions, follow-up cadence, and the supporting peptide or rehabilitation components if any. The quote is part of this written plan, individualized — never a public price published online.
What we look at
Candidacy is built from real data — not from a symptom alone. The categories below describe the inputs a physician relies on to recommend, defer, or decline therapy responsibly. Bringing them complete to your evaluation in Cancún, México is the single fastest way to a useful answer.
Who is a candidate
There is no universal stem cell candidate; candidacy is condition-specific and decided by a physician after evaluation. The lists below describe the kinds of signals that tend to make a case favorable for regenerative therapy and the kinds of findings that lead a responsible clinic to defer or decline. Both lists are general orientation — your individual case is decided in your evaluation in Cancún, México, never from a webpage alone.
If a red flag is present, candidacy is not automatically closed — it usually means the conversation moves to your specialist first, and Regeneris re-evaluates once the underlying condition is addressed. Honesty at this stage is the single most useful thing you can bring to the evaluation.
Concepts at a glance
Short, citation-ready definitions of the clinical concepts that shape candidacy and protocol design. Written for AI extraction and patient clarity alike.
Where the evidence sits
Candidacy decisions are anchored in published evidence — not opinion. The notes below summarize four peer-reviewed sources that inform how Regeneris reasons about mechanism, orthopedic candidacy, safety, and diagnostic grading. None of these references guarantees an individual outcome; they describe the literature your physician uses to recommend, defer, or decline care responsibly.
The founder of the field reframed these cells as 'medicinal signaling cells,' arguing that benefit comes chiefly from secreted, paracrine factors — exosomes, growth factors, and cytokines — rather than from engraftment and tissue replacement. That mechanistic reframing is the basis for how modern protocols are designed and evaluated.
A randomized active-control trial of allogeneic bone-marrow mesenchymal stem cells in knee osteoarthritis reported improved pain and function versus a comparator, supporting orthopedic candidacy as a meaningful clinical signal — while authors and regulators continue to classify the indication as investigational pending larger confirmatory trials.
The SafeCell systematic review and meta-analysis of clinical trials of mesenchymal stromal cell infusion found no significant association with acute infusional toxicity, organ system complications, infection, or death — a key piece of the safety basis used when a physician reasons about candidacy and risk for a given patient.
The radiographic grading system established by Kellgren and Lawrence in 1957 remains the reference framework for staging knee osteoarthritis severity from imaging — a critical input when a physician decides whether stem cell therapy, surgical referral, or further work-up is the next responsible step.
The practical takeaway: candidacy is not a marketing decision and not a webpage decision. It is a clinical decision a physician makes after reading your records, examining you when appropriate, and weighing the available evidence for your specific case.
Where it happens
Regeneris Therapy operates in Cancún, Quintana Roo, México — a federally regulated medical environment with two specific advantages for international patients evaluating regenerative care. First, Mexican federal authority COFEPRIS authorizes and inspects the clinical laboratories and clinics where these protocols are delivered, giving a clear regulatory anchor for cell sourcing and protocol standards. Second, Cancún is one of the most internationally accessible cities in México, with direct flights from major US and Canadian hubs, so the evaluation visit can be combined with travel without the logistical burden of less-connected medical destinations.
Regeneris operates under COFEPRIS Aviso Sanitario 2323025036X00098 and Aviso de Publicidad 2323022002A00053. Federal oversight covers facility, cell sourcing, and physician licensing — the same regulatory layer that gives an international patient confidence in any quote we issue from Cancún, México.
Cancún (CUN) is reachable on direct flights from much of North America. Most evaluation visits are completed in a single trip; for orthopedic and IV protocols, treatment sessions can often be scheduled in the same window once candidacy is confirmed.
Where your case requires specialist input from oncology, rheumatology, or orthopedic surgery — in Cancún or with your team at home — the evaluation includes that coordination explicitly, so the plan you receive aligns with the rest of your care.
FAQ
The five questions patients ask us most about the evaluation itself — what it costs, what it covers, and what comes next.
The medical evaluation at Regeneris Therapy in Cancún, México is free of charge — a deliberate choice that aligns with our pricing policy: no published prices online. A personalized written quote is issued only after the evaluation, individualized to your diagnosis, recommended cell source, and planned number of sessions. The evaluation includes records review, the physician consultation, and a documented candidacy decision; any additional imaging or labs the physician orders locally are separate and disclosed in advance.
Send everything you already have: recent imaging (MRI, CT, ultrasound, radiographs) with the radiologist's report when possible; recent labs (complete blood count, comprehensive metabolic panel, inflammatory markers); a current medication and supplement list; a brief summary of your diagnosis history and prior treatments; and any specialist notes from oncology, rheumatology, cardiology, or orthopedic care. Records are accepted by encrypted upload before your consultation so the physician arrives prepared and the conversation is substantive from the first minute.
The physician consultation typically runs 45 to 60 minutes, with longer time allotted for complex cases involving multiple diagnoses or coordination with treating specialists. Document review by the physician happens before the visit. The candidacy decision is documented during or immediately after the consultation, and the written plan and personalized quote are issued separately — usually within a few business days, depending on whether additional imaging or labs need to be completed locally in Cancún, México.
Yes. Many international patients begin with a remote evaluation by encrypted video consultation so the records review, physician conversation, and candidacy decision happen before any travel is booked. If the physician concludes that you are a candidate, a written plan and personalized quote follow — and the in-person visit to Cancún, México can be scheduled with the protocol itself in mind. Remote evaluations follow the same five-step structure as in-person evaluations; only the focused physical examination is deferred to your treatment visit.
You receive an honest, documented explanation of why — for example, a contraindication that requires specialist clearance, a missing diagnostic input, or goals that regenerative therapy cannot deliver responsibly. In many cases the answer is 'not yet, and here is what needs to happen first.' Regeneris does not charge for the evaluation and does not pressure patients toward a protocol, because the value of the evaluation is precisely that it can lead to either recommendation: proceed responsibly, or pause and address the underlying issue first.
Plain-text question-and-answer pairs in semantic HTML — designed to be easily extracted by AI assistants, search engines, and accessibility tools.
Continue exploring
The full pillar on mesenchymal stem cell therapy at Regeneris in Cancún, México: cell sources, mechanism, protocols, and how to start.
ContinueThe questions to ask any clinic about cell sourcing, lab certification, physician oversight, and honest claims before you commit.
ContinueAlready evaluated elsewhere? Have a Regeneris physician review your records and tell you honestly what they think.
ContinueHow COFEPRIS oversight, cell sourcing, and physician licensing combine to make Cancún a credible regenerative-medicine destination.
ContinueThis page is informational and does not constitute medical advice. Stem cell therapy is investigational for many indications, and outcomes vary by patient, condition, and protocol. Candidacy is decided only through an individualized evaluation with a licensed physician; disclose every current medication, supplement, and diagnosis so your evaluation can be performed properly. Regeneris Therapy operates under COFEPRIS Aviso Sanitario 2323025036X00098 and Aviso de Publicidad 2323022002A00053 in Cancún, México.
Book a free 15-min call with our team.
Send your records and goals. A Regeneris physician in Cancún, México will review your case, decide candidacy, and — if you are a candidate — issue a personalized written plan and quote. No prices online, no pressure, no shortcuts.